• BridgeBio Pharma average return on equity for 2023 was 45.72, a 18.42% decline from 2022.
• BridgeBio Pharma average return on equity for 2022 was 56.04, a 218.68% decline from 2021.
• BridgeBio Pharma average return on equity for 2021 was -47.22, a 56.3% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.